3 US Penny Stocks With Market Caps Up To $400M

In This Article:

As the U.S. stock market reaches record highs following Donald Trump's election victory, investors are keenly observing how different sectors and asset classes will perform under the new administration. Amidst this backdrop, penny stocks—often representing smaller or newer companies—remain a point of interest for those seeking unique investment opportunities. Though the term 'penny stock' might sound like a relic of past trading days, these stocks can still offer significant growth potential when backed by solid financials and strategic positioning in today's evolving market landscape.

Top 10 Penny Stocks In The United States

Name

Share Price

Market Cap

Financial Health Rating

BAB (OTCPK:BABB)

$0.80735

$5.81M

★★★★★★

RLX Technology (NYSE:RLX)

$1.60

$2.05B

★★★★★★

LexinFintech Holdings (NasdaqGS:LX)

$3.59

$588.6M

★★★★★★

QuantaSing Group (NasdaqGM:QSG)

$3.08

$173.78M

★★★★★★

PHX Minerals (NYSE:PHX)

$3.50

$129.74M

★★★★★☆

ZTEST Electronics (OTCPK:ZTST.F)

$0.26

$9.77M

★★★★★★

Flexible Solutions International (NYSEAM:FSI)

$3.9606

$50.3M

★★★★★★

Golden Growers Cooperative (OTCPK:GGRO.U)

$4.50

$69.71M

★★★★★★

Zynerba Pharmaceuticals (NasdaqCM:ZYNE)

$1.30

$65.6M

★★★★★☆

So-Young International (NasdaqGM:SY)

$1.25

$91.21M

★★★★☆☆

Click here to see the full list of 750 stocks from our US Penny Stocks screener.

Let's dive into some prime choices out of the screener.

Paysign

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Paysign, Inc. offers prepaid card programs, patient affordability solutions, digital banking services, and integrated payment processing for businesses, consumers, and government entities with a market cap of $203.52 million.

Operations: Paysign, Inc. has not reported any specific revenue segments at this time.

Market Cap: $203.52M

Paysign, Inc. has demonstrated strong financial performance with significant earnings growth of 420.5% over the past year, surpassing industry averages. The company is debt-free, with short-term assets exceeding both short and long-term liabilities, contributing to financial stability. Recent earnings reports show a rise in revenue and net income compared to the previous year, reflecting high-quality past earnings and improved profit margins from 3.5% to 14.3%. Despite this positive trajectory, insider selling over the last quarter may warrant caution for potential investors considering its inclusion in portfolios focused on penny stocks.

NasdaqCM:PAYS Debt to Equity History and Analysis as at Nov 2024
NasdaqCM:PAYS Debt to Equity History and Analysis as at Nov 2024

Nautilus Biotechnology

Simply Wall St Financial Health Rating: ★★★★★★

Waiting for permission
Allow microphone access to enable voice search

Try again.